Doximity (DOCS) reported $185.05 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 9.8%. EPS of $0.46 for the same period compares to $0.45 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $181.03 million, representing a surprise of +2.23%. The company delivered an EPS surprise of +4.55%, with the consensus EPS estimate being $0.44.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Doximity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Doximity here>>>
Shares of Doximity have returned -24.2% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 8 hours | |
| Nov-05 | |
| Nov-05 | |
| Nov-05 | |
| Nov-05 | |
| Nov-05 | |
| Oct-29 | |
| Oct-28 | |
| Oct-20 | |
| Oct-20 | |
| Oct-20 | |
| Oct-15 | |
| Oct-14 | |
| Oct-13 | |
| Oct-13 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite